CHAD KENNEDY: Open Payments
NPI 1366805178 · TROY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 28 payments from 9 companies in 2025. Trend: 2023 $258 · 2024 $446 · 2025 $1,199
Food & beverage: $1,195Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $282 |
| Janssen Pharmaceuticals, Inc | 3 | $241 |
| Alkermes, Inc. | 5 | $219 |
| Xeris Pharmaceuticals, Inc. | 1 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $106 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: VRAYLAR, LYBALVI, RECORLEV, INVEGA SUSTENNA, SPRAVATO, AUSTEDO XR, CAPLYTA, REXULTI.
Industry payments across OH — which companies pay providers there.
